A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid Tumors

Clinical trial NCT02834247 · TERMINATED

Trial details

NCT number: NCT02834247
Sponsor: Calithera Biosciences, Inc
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Triple-Negative Breast Neoplasms Carcinoma, Non-Small-Cell Lung Head and Neck Carcinoma, Squamous Cell Advanced Solid Tumors

Start date: 2016-08-12
Primary completion: 2018-11-30
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.